Inter Parfums Q3 sales
This article was originally published in The Rose Sheet
Executive Summary
Net sales in the third quarter grew 15% to $77.2 mil., boosted by Burberry fragrance sales, which continued to perform strongly despite a difficult comparison to the prior year period, in which Burberry Brit for Men launched, company reports Oct. 17. Lanvin Eclat d'Arpège and "to a lesser extent" the debut of Christian LaCroix Tumulte and Celine Fever contributed to the gain, Inter Parfums adds. Firm anticipates continued strong sales in Q4, bolstered by the launch of Burberry Brit Gold and Lanvin Arpege Pour Homme this fall(1"The Rose Sheet" Oct. 3, 2005, p. 7). For the nine-month period, revenues advanced 22% to $210 mil. Inter Parfums will release Q3 operating results the week of Nov. 7...
You may also be interested in...
Inter Parfums
Due to a reassignment of certain items from the third fiscal quarter to the fourth quarter, net sales in Q3 are revised to approximately $75.5 mil., a decrease from the previously released $77.2 mil. figure, fragrance manufacturer and distributor announces Oct. 31. "The revision to net sales was a result of timing only," company notes. For the nine-month period, sales were approximately $207.9 mil., not $210 mil. as previously stated, according to the company. Sales numbers were originally released Oct. 17 (1"The Rose Sheet" Oct. 24, 2005, In Brief). Firm reaffirms 2005 sales guidance of approximately $274 mil. and net income of $14.6 mil...
Procter & Gamble Prestige To Distribute New Lanvin, Burberry Scents
Arpège pour Homme by Lanvin is a reinterpretation of the Lanvin brand with a modern, refined positioning, according to Procter & Gamble Prestige Products, which distributes the line in the U.S. for licensee Inter Parfums
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.